Influence of dizocilpine (MK-801) on neurotoxic effect of dexamethasone: Behavioral and histological studies

Acta Neurobiologiae Experimentalis

Volumn 66, Issue 3, 2006, Pages 215-226

  Danilczuk, Zofia ^a   Sekita Krzak, Joanna ^a   Łupina, Tomasz ^a   Danilczuk, Marcin ^a   Czerny, Krystyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Body weight; Dexamethasone; Dizocilpine MK 801; Lethality; Long term memory; Mice; Morphological and ultrastructural study; Motor coordination

Indexed keywords

DEXAMETHASONE; DIZOCILPINE; DIZOCILPINE MALEATE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BRAIN NERVE CELL; BRAIN NUCLEUS; CELL STRUCTURE; CELL ULTRASTRUCTURE; CYTOPLASM; DOSE RESPONSE; DRUG EFFECT; HIPPOCAMPUS; HISTOPATHOLOGY; LETHALITY; LONG TERM MEMORY; MALE; MOTOR COORDINATION; MOUSE; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BODY WEIGHT; DEXAMETHASONE; DIZOCILPINE MALEATE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROTOXINS; RATS; RETENTION (PSYCHOLOGY); STATISTICS, NONPARAMETRIC;

EID: 33750984802     PISSN: 00651400     EISSN: 00651400     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Adams DM, Kinney TR, O'Branski-Rupp E, Ware RE (1996) High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura. J Pediatr 128: 281-283.
2. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F (1997) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138: 101-106.
3. Bertorelli R, Adami M, Di Santo E, Ghezzi P (1998) MK-801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci Lett 246: 41-44.
4. Boissier JR, Tardy J, Diverres JC (1960) A new method for exploration the activity of "tranquillizers": The chimney test (in French). Méd Exp (Basel) 81-84.
5. Borst F, KeuningJJ, van Hulsteijn H, Sinnige H, Vreugdenhil G (2004) High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 83: 764-768.
6. Brown ES, Rush AJ, McEwen BS (1999) Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders. Neuropsychopharmacology 21: 474-484.
7. Byrne JD, Incerpi MH, Goodwin TM (1997) Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed high-dose oral dexamethasone. Am J Obstet Gynecol 177: 468-469.
8. Chen J, Adachi N, Tsubota S, Nagoro T, Arai T (1998) Dexamethasone augments ischemia-induced extracelluralar accumulation of glutamate in gerbil hippocampus. Eur J Pharmacol 347: 67-70.
9. Danilczuk Z, Ossowska G, Wróbel A, Lupina T (2001) Glucocorticoids modulate behavioral effects induced by dopaminergic agonists in rats. Pol J Pharmacol 53: 467-473.
10. Danilczuk Z, Ossowska G, Łupina T, Cieślik K, Żebrowska-Łupina I (2005) Effect of NMDA receptor antagonists on behavioural impairment induced by chronic treatment with dexamethasone. Pharmacol Reports 57: 47-54.
11. Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: Preclinical evidence. Int J Geriatr Psychiatry 18: 23-32.
12. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 211: 455-468.
13. De Quervain DJ, Roozendaal B, McGaugh JL (1998) Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394: 787-790.
14. Ellison G (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev 20: 250-267.
15. Elmariah SB, Crumling MA, Parsons TD, Balice-Gordon R (2004) Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses. J Neurosci 24: 2380-2393.
16. Endo Y, Nishimura JI, Kimura F (1996) Impairment of maze learning in rats following long-term glucocorticoid treatment. Neurosci Lett 203: 199-202.
17. Estupina C, Abarca J, Arancibia S, Belmar J (1996) N-methyl-D-aspartate receptor involvement in dexamethasone- and stress-induced hypothalamic somatostatin release in rats. Neurosci Lett 29: 203-206.
18. Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, Peter HS, Olney JW (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? Biol Psychiatry 38: 788-796.
19. Feldman S, Weidenfeld J (1997) Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis. J Neural Transm 104: 633-642.
20. Flavin MP (1996) Influence of dexamethasone on neurotoxicity caused by oxygen and glucose deprivation in vitro. Exp Neurol 139: 34-38.
21. Fonnum F, Myhrer T, Paulsen RE, Wangen K, Oksengard AR (1995) Role of glutamate and glutamate receptors in memory function and Alzheimer's disease. Ann N Y Acad Sci 757: 475-486.
22. Fuchs E, Flügge G (1998) Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev 23: 295-300.
23. Griffiths MR, Cooper AJ, Barber DJ, Mitchell IJ (2000) Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: The roles of glutamate, dopamine, acetylcholine and cortocosteroids. Brain Res 855: 1-10.
24. Gorgulu A, Kins T, Cobanoglu S, Unal F, Izgi NI, Yanik B, Kucuk M (2000) Reduction of edema and infarction by memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir 142: 1287-1292.
25. Haynes LE, Griffiths MR, Hyde RE, Barber DJ, Mitchell U (2001) Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: Implications for mood disorders. Neuroscience 104: 57-69.
26. Ikonomidou Ch, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, Tenkova TI (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
27. Ikonomidou Ch, Stefovska V, Turski L (2000) Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci U S A 97: 12885-12890.
28. Ismail K, Wessely S (1995) Psychiatric complications of corticosteroid therapy. Br J Hosp Med 53: 495-499.
29. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT (1996) The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47: 1396-1402.
30. Kiraly SJ, Ancill RJ, Dimitrova G (1997) The relationship of endogenous cortisol to psychiatric disorder: A review. Can J Psychiatry 42: 415-420.
31. Kornhuber J, Weller M (1997) Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy. Biol Psychiatry 41: 135-144.
32. Kreuter A, Altmeyer P (2005) High-dose dexamethasone in scleromyxedema: Report of 2 additional cases. J AM Acad Dermatol 53: 739-740.
33. Martignoni E, Costa a, Sinforiani E, Liuzzi A, Chiodini P Mauri M, Bono G, Nappi GP (1992) The brain as a target for adrenocortical steroids: Cognitive implications. Psychoneuroendocrinology 17: 343-354.
34. McEwen BS, Angulo I, Cameron H, Chao HM (1992) Parodixal effects of arenal steroids on the brain: Protection versus degeneration. Biol Psychiatry 31: 177-199.
35. McIntosh LJ, Sapolsky R (1996) Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamyein-induced toxicity in neuronal culture. Expl Neurol 141: 201-206.
36. Meetze W, Shenoy V, Martin G, Musy P, Neu J (1992) Ontogeny of small intestinal (SI) glutaminase (G) and glutamine synthetase (GS) in the rat: Response to dexamethasone (DEX). Pediatr Res 31: 112A
37. Misztal M, Frankiewicz T, Parson ChG, Danysz W (1996) Learning deficits induced by chronic intraventricular infusion of quinolinic acid - protection by MK-801 and memantine. Eur J Pharmacol 296: 1-8.
38. Mitchell IJ, Cooper AJ, Griffiths MR, Barber DJ (1998) Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: A neuronal substrate for psychosis? Neuroscience 84: 489-501.
39. Mondadori C, Weiskrantz L (1993) NMDA receptor blockers facilitate and impair memory via different mechanism. Behav Neural Biol 60: 205-210.
40. Morita K, Ishimura K, Tsuruo Y, Wong DL (1999) Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors. Brain Res 816: 309-316.
41. Muir KW, Lees KR (1995) Clinical experience with excitatory amino acid antagonist drugs. Stroke 26: 503-513.
42. Naumovski J, Bozinovska C, Kovkarova E, Petkovska L (2003) Single-dose dexamethasone-induced adrenocortical suppression in an intentional self-poisoning - case report. Clin Toxicol 41: 895.
43. Newcomer JW, Selke G. Melson A K, Hershey T, Craft S, Richards K, Alderson A (1999) Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 556: 527-533.
44. Norra Ch, Arndt M, Kunert H J (2006) Steroid dementia: An overlooked diagnosis? Neurology 66: 155-158.
45. Olney JW, Farber NB (1995a) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13: 335-345.
46. Olney JW, Farber NB (1995b) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998-1007.
47. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38: 735-767.
48. Qiang Li, Clark S, Lewis DV, Wilson WA (2002) NMDA receptor antagonists disinhibit rat posterior cingulated and retrosplenial cortices: A potential mechanism of neurotoxicity. J Neurosci 22: 3070-3080.
49. Roesler R, Vianna MRM, de-Paris F, Quevedo J (1999) Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade. Neurobiol Learn Mem 72: 252-258.
50. Roozendaal B, McGaugh JL (1996) Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiol Learn Mem 65: 1-8.
51. Seckl JR, Olsson T (1995) Glucocorticoid hypersecretion and the age-impaired hippocampus: Cause or effect? J Endocrinol 145: 201-211.
52. Sekita-Krzak J, Żebrowska-Łupina I, Wróbel A, Koziej J (1999) Neurotoxic effects of glucocorticosteroids: Morphological examinations of hippocampal cells after experimental administration of dexamethasone. Ann Univ Mariae Curie Sklodowska 54: 167-172.
53. Sekita-Krzak J, Żebrowska-Łupina I, Czerny K, Stȩpniewska M, Wróbel A (2003) Neuroprotective effect of ACTH(4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: Morpological, immunocytochemical and ultrastructural studies. Acta Neurobiol Exp (Wars) 63: 1-8.
54. Skup M, Dwornik A, Macias M, Sulejczak D, Wiater M,Czarkowska-Bauch J (2002) Long-term locomotor training up-regulates TrkBFL receptor-like proteins, brain-derived neurotrophic factor, and neurotrophin 4 with different topographies of expression in oligodendroglia and neurons in the spinal cord. Exp Neurol 176: 289-307.
55. Sousa N, Paula-Barbosa M, Almeida O (1999) Ligand and subfield specificity of corticoid-induced neuronal loss in the rat hippocampal formation. Neuroscience 89: 1079-1087
56. Stuart FA, Segal TY, Keady S (2005) Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 90: 500-506.
57. Suzuki K, Sato M, Morishima Y, Nakanishi S (2005) Neuronal depolarization controls brain-derived neurotrophi factor-induced upregulation of NR2C NMDA receptor via calcineurin signaling. J Neurosci 25: 9535-9543
58. Van der Meulen MFG, Hoogendijk JE, Wokke JHJ, de Visser M (2000) Oral pulsed high-dose dexamethasone foe myositis. J Neurol 247: 102-105.
59. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepines impair and betacorbolines enhance performance in learning and memory tasks. Nature 321: 864-866.
60. Watanabe Y, Gould E, McEwen B (1992) Stress induced atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 588: 341-345.
61. Wolkowitz OM, Reus VI (1999) Treatment of depression with antiglucocorticoid drugs. Psychosom Med 61: 698-711.
62. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997) Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci 823: 81-96.
63. Woźniak D, Brosnan-Watters G, Nardi A, McEwen M, Corso T, Olney J Fix A (1996) MK-801 neurotoxicity in male mice: Histologic effects and chronic impairment in spatial learning. Brain Res 707: 165-179.
64. Young AH, Sahakian BJ, Robbins TW, Cowe PJ (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal volunteers. Psychopharmacology 145: 260-266.
65. Zaja̧czkowski W, Frankiewicz T, Parsons CG, Danysz W (1997) Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LPT. Neuropharmacology 36: 961-971.
66. Zaja̧czkowski W, Hetman M, Nikolaev E, Quack G, Danysz W, Kaczmarek L (2000) Behavioural evaluation of long-term neurotoxic effects of NMDA receptor antagonists. Neurotox Res 1: 299-310.